StockUS listing USLHNYSEHealthcareValue Trap

Laboratory Corporation of America Holdings(LH) Stock Analysis | Healthcare

USD --+0.00%
Reward42Moderate
Risk45Moderate
75%Data
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 25.32Bn
Reward Ratingⓘ42 Moderate reward assessment · 75% data coverage
Bottom 10% of stocksView factors
Risk Ratingⓘ45 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on LH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Laboratory Corporation of America Holdings?

It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.

AI Brief Pro

The brief on Laboratory Corporation of America Holdings

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Laboratory Corporation of America Holdings?

It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 25.32B, and a P/E ratio of 26.0x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (42)

Similar stocks to compare

A short list of Diagnostics & Research names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryDiagnostics & Research
P/E Ratio25.9908
Beta0.846
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
516,113 shares
$4.5M
0
9-12months
212,754 shares
$3.3M
0

Openbook research

Articles mentioning LH

1